These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

441 related items for PubMed ID: 34775125

  • 1. Silk fibroin-capped metal-organic framework for tumor-specific redox dyshomeostasis treatment synergized by deoxygenation-driven chemotherapy.
    Yu H, Li Y, Zhang Z, Ren J, Zhang L, Xu Z, Kang Y, Xue P.
    Acta Biomater; 2022 Jan 15; 138():545-560. PubMed ID: 34775125
    [Abstract] [Full Text] [Related]

  • 2. A multifunctional metal-organic framework nanosystem disrupts redox homeostasis for synergistic therapy.
    Sun Y, Du X, Liang J, Wang D, Zheng J, Bao Z, Zhao Z, Yuan Y.
    J Colloid Interface Sci; 2023 Sep 15; 645():607-617. PubMed ID: 37167910
    [Abstract] [Full Text] [Related]

  • 3. Hypoxia-Triggered Nanoscale Metal-Organic Frameworks for Enhanced Anticancer Activity.
    Liu M, Wang L, Zheng X, Liu S, Xie Z.
    ACS Appl Mater Interfaces; 2018 Jul 25; 10(29):24638-24647. PubMed ID: 29957930
    [Abstract] [Full Text] [Related]

  • 4. Microenvironment-driven sequential ferroptosis, photodynamic therapy, and chemotherapy for targeted breast cancer therapy by a cancer-cell-membrane-coated nanoscale metal-organic framework.
    Pan WL, Tan Y, Meng W, Huang NH, Zhao YB, Yu ZQ, Huang Z, Zhang WH, Sun B, Chen JX.
    Biomaterials; 2022 Apr 25; 283():121449. PubMed ID: 35247637
    [Abstract] [Full Text] [Related]

  • 5. MnO2-capped silk fibroin (SF) nanoparticles with chlorin e6 (Ce6) encapsulation for augmented photo-driven therapy by modulating the tumor microenvironment.
    Zhang L, Yang R, Yu H, Xu Z, Kang Y, Cui H, Xue P.
    J Mater Chem B; 2021 May 05; 9(17):3677-3688. PubMed ID: 33949613
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Programmed Release of Dihydroartemisinin for Synergistic Cancer Therapy Using a CaCO3 Mineralized Metal-Organic Framework.
    Wan X, Zhong H, Pan W, Li Y, Chen Y, Li N, Tang B.
    Angew Chem Int Ed Engl; 2019 Oct 01; 58(40):14134-14139. PubMed ID: 31389105
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Programmable therapeutic nanoscale covalent organic framework for photodynamic therapy and hypoxia-activated cascade chemotherapy.
    He H, Du L, Xue H, Wu J, Shuai X.
    Acta Biomater; 2022 Sep 01; 149():297-306. PubMed ID: 35811069
    [Abstract] [Full Text] [Related]

  • 15. Ultrasound (US)-activated redox dyshomeostasis therapy reinforced by immunogenic cell death (ICD) through a mitochondrial targeting liposomal nanosystem.
    Ren J, Zhou J, Liu H, Jiao X, Cao Y, Xu Z, Kang Y, Xue P.
    Theranostics; 2021 Sep 01; 11(19):9470-9491. PubMed ID: 34646381
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Controllable hypoxia-activated chemotherapy as a dual enhancer for synergistic cancer photodynamic immunotherapy.
    Wang M, He M, Zhang M, Xue S, Xu T, Zhao Y, Li D, Zhi F, Ding D.
    Biomaterials; 2023 Oct 01; 301():122257. PubMed ID: 37531778
    [Abstract] [Full Text] [Related]

  • 18. Targeting triple-negative breast cancer with an aptamer-functionalized nanoformulation: a synergistic treatment that combines photodynamic and bioreductive therapies.
    Chou YT, Lin CY, Wen JW, Hung LC, Chang YF, Yang CM, Wu LC, Ho JA.
    J Nanobiotechnology; 2021 Mar 29; 19(1):89. PubMed ID: 33781277
    [Abstract] [Full Text] [Related]

  • 19. A tumor microenvironment-responsive poly(amidoamine) dendrimer nanoplatform for hypoxia-responsive chemo/chemodynamic therapy.
    Hao Y, Gao Y, Fan Y, Zhang C, Zhan M, Cao X, Shi X, Guo R.
    J Nanobiotechnology; 2022 Jan 21; 20(1):43. PubMed ID: 35062953
    [Abstract] [Full Text] [Related]

  • 20. Enzyme/GSH dual-responsive biodegradable nanohybrid for spatiotemporally specific photodynamic and hypoxia-augmented therapy against tumors.
    Cheng D, Ji Y, Wang B, Jin T, Xu Y, Qian X, Zhu W.
    Int J Pharm; 2021 Jun 15; 603():120730. PubMed ID: 34029662
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.